Inventor · disambiguated record
Ping Zhang
Also filed as: ZHANG PING · ZHANG PING SHENG
21 granted patents·16 pending applications·117 citations·filing 1998–2024
94Inventor score
Top patents by PatentIndex Score
37 records- 0197US7858749B2Polymer-factor VIII moiety conjugatesNEKTAR THERAPEUTICS·Filed 2007·Granted Dec 28, 2010·14 cites·19 claims
- 0294US8247536B2Factor VIII compositionsBOSSARD MARY J·Filed 2009·Granted Aug 21, 2012·8 cites·27 claims
- 0394US8143378B2Polymer factor VIII moiety conjugatesBOSSARD MARY J·Filed 2009·Granted Mar 27, 2012·7 cites·27 claims
- 0494US8133977B2Polymer-factor VIII moiety conjugatesBOSSARD MARY J·Filed 2009·Granted Mar 13, 2012·7 cites·33 claims
- 0594US7863421B2Polymer-factor VIII moiety conjugatesNEKTAR THERAPEUTICS·Filed 2008·Granted Jan 4, 2011·14 cites·40 claims
- 0692US8889831B2Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugateBOSSARD MARY J·Filed 2012·Granted Nov 18, 2014·4 cites·40 claims
- 0791US9999657B2Polymer-factor VIII moiety conjugatesNEKTAR THERAPEUTICS·Filed 2015·Granted Jun 19, 2018·2 cites·22 claims
- 0885US9682153B2Polymer conjugates of therapeutic peptidesNEKTAR THERAPEUTICS·Filed 2015·Granted Jun 20, 2017·3 cites·12 claims
- 0982US11141465B2Method of making a water-soluble polymer-factor VIII moiety conjugateNEKTAR THERAPEUTICS·Filed 2018·Granted Oct 12, 2021·1 cites·12 claims
- 1081US2021401948A1Polymer-factor viii moiety conjugatesNEKTAR THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1179US6020328A20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal propertiesRES TRIANGLE INST·Filed 1998·Granted Feb 1, 2000·53 cites·9 claims
- 1277US8618259B2Polymer-factor VIII conjugate compositionsBOSSARD MARY J·Filed 2012·Granted Dec 31, 2013·1 cites·33 claims
- 1377US8519102B2Polymer Factor VIII moiety conjugatesBOSSARD MARY J·Filed 2012·Granted Aug 27, 2013·1 cites·29 claims
- 1473US8133865B2von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkageBOSSARD MARY J·Filed 2007·Granted Mar 13, 2012·1 cites·27 claims
- 1569US2015038422A1Unit dosage forms of pharmaceutical compositions comprising a polymer-factor viii polypeptide conjugateNEKTAR THERAPEUTICS·Filed 2014·Application pending·0 cites
- 1667US12036283B2Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methodsNEKTAR THERAPEUTICS·Filed 2018·Granted Jul 16, 2024·1 cites·28 claims
- 1765US2024424115A1Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methodsNEKTAR THERAPEUTICS·Filed 2024·Application pending·0 cites
- 1862US9950080B2Amphiphilic cyclodextrin-based glycodendrimersUTI LP·Filed 2014·Granted Apr 24, 2018·0 cites·13 claims
- 1961US8349800B2Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkageNEKTAR THERAPEUTICS·Filed 2012·Granted Jan 8, 2013·0 cites·20 claims
- 2060US9493544B2Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkageBOSSARD MARY J·Filed 2012·Granted Nov 15, 2016·0 cites·20 claims
- 2160US2014044672A1Conjugates of a gm-csf moiety and a polymerNEKTAR THERAPEUTICS·Filed 2013·Application pending·0 cites
- 2260US2006036080A1Conjugates of GM-CSF moiety and a polymerBOSSARD MARY J·Filed 2005·Application pending·0 cites
- 2359US2025145600A12-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesityNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2455US9274122B2Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)VARADI KATALIN·Filed 2009·Granted Mar 1, 2016·0 cites·19 claims
- 2554US2006233740A1Conjugates of an hGH moiety and a polymerBOSSARD MARY J·Filed 2006·Application pending·0 cites
- 2654US2024182456A12-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesityNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2753US2019070251A1Polymer conjugates of therapeutic peptidesNEKTAR THERAPEUTICS·Filed 2017·Application pending·0 cites
- 2851US2011165113A1Polymer conjugates of v681-like peptidesNEKTAR THERAPEUTICS·Filed 2009·Application pending·0 cites
- 2949US2018318445A1Amphiphilic cyclodextrin-based glycodendrimersUTI LP·Filed 2018·Application pending·0 cites
- 3048US2012195847A1Polymer conjugates of biphalin peptidesWANG YUJUN·Filed 2009·Application pending·0 cites
- 3147US11717580B2Cyclodextrin-linked polyvalent ligands for complexation of metal ionsUTI LP·Filed 2019·Granted Aug 8, 2023·0 cites·20 claims
- 3247US10662260B2Cyclodextrin-based polyanionic and non-ionic dendrimersUTI LP·Filed 2015·Granted May 26, 2020·0 cites·6 claims
- 3346US11365212B2Fluorinated N-acetyl glucosamine analogs and xylose derivativesUTI LP·Filed 2019·Granted Jun 21, 2022·0 cites·2 claims
- 3445US2007092482A1Conjugates of a G-CSF moiety and a polymerBOSSARD MARY J·Filed 2006·Application pending·0 cites
- 3537US2018280537A1Multifunctional polyanionic cyclodextrin dendrimersUTI LP·Filed 2016·Application pending·0 cites
- 3635US2019290733A1Conjugates of an il-7 moiety and a polymerNEKTAR THERAPEUTICS·Filed 2016·Application pending·0 cites
- 3727US2018296679A1Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereofLING CHANG CHUN·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ping Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →